A Phase 1b/2 open-Label Trial of Tisotumab Vedotin (Humax-TF-ADC) Monotherapy and in combination with other Agents in Subjects with recurrent or Stage IVB Cervical Cancer
Trial Number
NCT03786081Contact Person
Status
Closed to Recruitment
Disease Site
Cervical
Lead Cooperative Group
Participating Groups
GOG-F
CEEGOG
CTI
DGOG
NCRI
SGCTG
NSGO-CTU
MITO
GEICO